Partial suppression of type 2 inflammation with mepolizumab
| Errataetall: |
CommentOn: J Allergy Clin Immunol Pract. 2022 Nov;10(11):2925-2934.e12. - PMID 35863669 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
The journal of allergy and clinical immunology. In practice - 10(2022), 12 vom: 01. Dez., Seite 3343 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stewart, Kirsten E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.12.2022 Date Revised 05.01.2023 published: Print CommentOn: J Allergy Clin Immunol Pract. 2022 Nov;10(11):2925-2934.e12. - PMID 35863669 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaip.2022.08.053 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350084289 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350084289 | ||
| 003 | DE-627 | ||
| 005 | 20231226044142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaip.2022.08.053 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1166.xml |
| 035 | |a (DE-627)NLM350084289 | ||
| 035 | |a (NLM)36496220 | ||
| 035 | |a (PII)S2213-2198(22)00942-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stewart, Kirsten E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Partial suppression of type 2 inflammation with mepolizumab |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2022 | ||
| 500 | |a Date Revised 05.01.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Allergy Clin Immunol Pract. 2022 Nov;10(11):2925-2934.e12. - PMID 35863669 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Anti-Asthmatic Agents |2 NLM | |
| 700 | 1 | |a Chan, Rory |e verfasserin |4 aut | |
| 700 | 1 | |a Misirovs, Rasads |e verfasserin |4 aut | |
| 700 | 1 | |a Lipworth, Brian J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of allergy and clinical immunology. In practice |d 2013 |g 10(2022), 12 vom: 01. Dez., Seite 3343 |w (DE-627)NLM227247523 |x 2213-2201 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g number:12 |g day:01 |g month:12 |g pages:3343 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaip.2022.08.053 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |e 12 |b 01 |c 12 |h 3343 | ||